GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Vijaya Diagnostic Centre Ltd (NSE:VIJAYA) » Definitions » 3-Year EBITDA Growth Rate

Vijaya Diagnostic Centre (NSE:VIJAYA) 3-Year EBITDA Growth Rate : 10.30% (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Vijaya Diagnostic Centre 3-Year EBITDA Growth Rate?

Vijaya Diagnostic Centre's EBITDA per Share for the three months ended in Dec. 2024 was ₹6.99.

During the past 12 months, Vijaya Diagnostic Centre's average EBITDA Per Share Growth Rate was 24.60% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 10.30% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 13.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 6 years, the highest 3-Year average EBITDA Per Share Growth Rate of Vijaya Diagnostic Centre was 22.20% per year. The lowest was 9.70% per year. And the median was 10.30% per year.


Competitive Comparison of Vijaya Diagnostic Centre's 3-Year EBITDA Growth Rate

For the Diagnostics & Research subindustry, Vijaya Diagnostic Centre's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vijaya Diagnostic Centre's 3-Year EBITDA Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Vijaya Diagnostic Centre's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Vijaya Diagnostic Centre's 3-Year EBITDA Growth Rate falls into.


;
;

Vijaya Diagnostic Centre 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Vijaya Diagnostic Centre  (NSE:VIJAYA) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Vijaya Diagnostic Centre 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Vijaya Diagnostic Centre's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Vijaya Diagnostic Centre Business Description

Traded in Other Exchanges
Address
Ground Floor, FPAI Building, No 6-3-883/F, Punjagutta Officers Colony, Near Topaz Building, Hyderabad, TG, IND, 500 082
Vijaya Diagnostic Centre Ltd operates a diagnostic chain in Southern India. The company offers a one-stop solution for pathology and radiology testing services. It provides routine tests, specialized pathology tests, basic tests, and advanced radiology tests. The company also offers a broad spectrum of customized health and wellness packages to its customers. The company's revenue comes from many diagnostic centers, where high-volume sales drive its earnings. The Company operates within India. The company's operations fall within a single business segment, which is Diagnostic Services.

Vijaya Diagnostic Centre Headlines

No Headlines